A breast cyst is a noncancerous (benign), fluid-filled sac in the breast. Developed as a result of fluid accumulation inside the breast glands, this is found in women aged 20 to 50 years and it can be single or multiple. A cyst may feel like a grape or water balloon or firm.
Market Size & Growth Rate:
The breast cyst treatment market was valued at USD 530 million in 2021 and is projected to reach USD 865 million by 2027, with a CAGR of 7.3 % over the forecast period 2022-2027. The growth could be attributed to the return of demand to pre-pandemic levels, increasing authorization of novel & innovative medicines, extensive research, disease prevalence, and immunotherapies.
Market Dynamics:
- Various research studies show a high lifetime prevalence of fibrocystic breast disease in women. Over 70% of all women experience fibrocystic changes at some point in their life, with 20% of these women becoming symptomatic and 10% to 30% developing sclerosing adenosis.
- A breast cyst is estimated to affect 7% of all women in the United States at some point in their life. Breast cysts are most common in women aged 20 to 50 years. The incidence of cyst development increases throughout these years and then drops dramatically.
- Most benign cysts disappear, and new cysts stop developing a year after menopause, as cyst development is linked to hormone levels in the body.
- Moreover, living lifestyle, food habits, and psychological issues are finally impacting hormonal balance, these few factors are anticipated to propel the growth of the market.
Market Drivers:
- Fine-needle aspiration segment is expected to drive market growth
- If all the fluid in the cyst can be removed during the procedure, fine-needle aspiration can be used to diagnose and treat a breast cyst and the breast lump and symptoms disappear.
- However, some breast cysts may require more than one drainage procedure. Cysts that form new cysts are common. If a breast cyst persists for two to three menstrual cycles and grows, it should be treated. A small amount of breast tissue or fluid is removed from a suspicious area with a thin, hollow needle and checked for cancer cells during a fine needle aspiration.
- If other tests indicate that you may have breast cancer, this type of biopsy may be an option (although a core needle biopsy is often preferred). It can also be used in other conditions.
- The main benefits of FNA are that it is relatively quick, it rarely requires anesthesia, the skin is not cut, so no stitches are required, and there is usually no scar. In some cases, one can even get the results on the same day.
The increasing research & development are expected to drive the market growth.
Alcohol consumption increases the risk of breast cystic changes.
Challenges:
Identify the etiology of breast cysts.
- In general, the etiology of breast cysts is unknown. However, the majority of breast cysts are linked with abnormal development and compression.
- It is based on the research studies that all most all benign disorders of the breast are due to some minor abnormalities in the general processes of the physiological development of the breast following cyclical normal growth response.
- These cysts develop in any size, ranging, for example, a few millimeters to several centimeters, generally, the shape of cysts is oval or round and can grow quickly anywhere in the breast.
- Although more common in women, many women have cysts and don't feel them at all, because of the difficulty in identifying the condition of cysts.
- Professionals don't know exactly what causes breast cysts. They may develop as a result of hormonal changes from monthly menstruation.
Lack of awareness of breast cysts in developing nations.
High cost of imaging systems & side effects related to imaging.
Competitive landscape:
The global breast cyst treatment market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market such,
Pfizer, Sanofi, Merck, Teva Pharmaceutical Industries, Bayer AG, Allergan, Johnson and Johnson, Advin Health Care, Becton, Dickinson and Company, Swastik Enterprise, Argon Medical Devices, Inc., Somatex Medical Technologies GmbH, Remington Medical Inc., Hakko co., ltd., Bpb Medica
Key Developments:
- In August 2022, AstraZeneca in collaboration with Daiichi Sankyo received FDA nod for Enhertu. the drug which is directed to treat breast cancer patients exhibiting low HER2 protein in their tumors.
- In August 2021, NeoDynamics AB company has launched a product biopsy needle used in the NeoNavia FlexiPulse probe for developing breast cancer diagnosis and treatment.
- In April 2020, The FDA-approved Fisher's CytoCore fine needle device, which can be attached to a small needle, has an internal motor that rotates the needle during the biopsy.
Regional Analysis:
North America holds a key share of the global breast cysts treatment market in forecast periods. Extensive research on various segments like fine needle aspiration and good surgical devices has propelled revenue prospects. Especially the U.S. and Canada will contribute the largest revenue share in the forecast period. Additionally, the launch of innovative oral pills in the US will contribute to the growth of the regional Breast cysts treatment market. In addition, increasing investment and funding in research and development activities of breast cyst diagnostics and government initiatives to raise awareness among the people to propel the growth of the market. For instance, according to the National Cancer Institute research, around USD 574.9 million was funded for research on breast cancer including breast cysts.
Europe region is anticipated to be the second largest market share in the breast cysts treatment market due to the presence of sophisticated healthcare infrastructure & rising demand for the better healthcare facility, generous reimbursement policies by the government and growing awareness about early treatment for breast cyst among people are few other factors anticipated to propel the growth of the market and also, the increasing number of breast cyst screening programs is anticipated to drive market growth.
Asia Pacific's breast cysts treatment market is anticipated to increase at a promising growth rate in the next few years. A substantial advancement in medical infrastructure, along with growing awareness about the impacts of breast cysts on the quality of life of the affected, is boosting the prospects.
- As per Breast Screen Australia, women aged 50-74 in Australia are required to get free mammography every two years as part of the government's nationwide screening scheme.
Moreover, macroeconomic factors such as a large population and growing economy, speed prevalence of breast cysts, and growing investments push market access in key markets such as Japan, China, Australia, Singapore, and India.
The Middle East & Africa and Latin America are expected to show considerable growth in the breast cysts treatment market in the near future
Market Segmentation:
The global breast cyst treatment market estimates (Value USD Million) & Forecasts and Trend Analyses, 2022 to 2027 based on Treatment Type
- Surgeries
- Fine Needle Aspiration
- Radiotherapy
- Hormonal Therapy
The global breast cyst treatment market estimates (Value USD Million) & Forecasts and Trend Analyses, 2022 to 2027 based on End Users
- Hospitals
- Clinics
- Other
What is the breast cyst treatment market report about?
The breast cyst treatment market report discusses the commercial and clinical activity associated with applications. It provides insights on the total size of the potential opportunity, key segments driving growth, key challenges faced, and a thorough analysis of market competition by product, geography, indication, and forecasts through 2027. Detailed coverage of the approved breast cyst treatment, including regulatory approvals, pricing, reimbursement, and market penetration so, a new investor can potentially gain information about breast cyst treatment companies, their key products, their core strategy, key trends in the breast cyst treatment market, and more.
The breast cyst treatment market report is essential for all stakeholders including research companies, manufacturing companies, distribution companies, government agencies, and others.
- Capitalize on rapidly emerging trends
- Optimize decision-making
- Reduce company risk
- Approach partners/investors for collaboration or funding
- Implement an informed and advantageous business strategy in 2022
- Detailed coverage of the approved nuclear medicine therapeutics, including regulatory approvals, pricing, reimbursement, and market penetration
- Profiles of leading & upcoming breast cyst treatment competitors composing the global marketplace